Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Perazella

Showing results (11-20 of 278) with videos related to

Pageof 28
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2010
Nephrology fellowship training in the 21st century: where do we stand?Mark A Perazella
The American Journal of the Medical Sciences|June 18, 2003
Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicityMark A Perazella
Expert Opinion on Drug Safety|August 9, 2003
Efficacy and safety of midodrine in the treatment of dialysis-associated hypotensionMark A Perazella
Kidney360|September 26, 2024
Proton Pump Inhibitors and Kidney Disease: What Gives?Mark A Perazella
Journal of Hospital Medicine|May 2, 2017
Diagnostic Testing in AKI: Let's Move the Field ForwardMark A Perazella
Current Drug Safety|August 12, 2008
Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosisMark A Perazella
Clinical Journal of the American Society of Nephrology : CJASN|February 10, 2009
Current status of gadolinium toxicity in patients with kidney diseaseMark A Perazella
Clinical Journal of the American Society of Nephrology : CJASN|June 13, 2009
Renal vulnerability to drug toxicityMark A Perazella
Clinical Nephrology|April 3, 2014
Diagnosing drug-induced AIN in the hospitalized patient: a challenge for the clinicianMark A Perazella
Clinical Journal of the American Society of Nephrology : CJASN|April 4, 2008
How should nephrologists approach gadolinium-based contrast imaging in patients with kidney disease?Mark A Perazella
Pageof 28

Showing results (11-20 of 278) with videos related to

Sort By:
Pageof 28
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2010
Nephrology fellowship training in the 21st century: where do we stand?Mark A Perazella
The American Journal of the Medical Sciences|June 18, 2003
Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicityMark A Perazella
Expert Opinion on Drug Safety|August 9, 2003
Efficacy and safety of midodrine in the treatment of dialysis-associated hypotensionMark A Perazella
Kidney360|September 26, 2024
Proton Pump Inhibitors and Kidney Disease: What Gives?Mark A Perazella
Journal of Hospital Medicine|May 2, 2017
Diagnostic Testing in AKI: Let's Move the Field ForwardMark A Perazella
Current Drug Safety|August 12, 2008
Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosisMark A Perazella
Clinical Journal of the American Society of Nephrology : CJASN|February 10, 2009
Current status of gadolinium toxicity in patients with kidney diseaseMark A Perazella
Clinical Journal of the American Society of Nephrology : CJASN|June 13, 2009
Renal vulnerability to drug toxicityMark A Perazella
Clinical Nephrology|April 3, 2014
Diagnosing drug-induced AIN in the hospitalized patient: a challenge for the clinicianMark A Perazella
Clinical Journal of the American Society of Nephrology : CJASN|April 4, 2008
How should nephrologists approach gadolinium-based contrast imaging in patients with kidney disease?Mark A Perazella
Pageof 28